(Q33890707)

29 July 2017

2 references

25 April 2019

28 September 2019

Matrix metalloproteinases and their multiple roles in Alzheimer's disease (English)

1 reference

29 July 2017

2 references

25 April 2019

28 September 2019

1 reference

28 September 2019

Jin-Tai Yu

3

0 references

Lan Tan

series ordinal

4

object named as

Lan Tan

1 reference

29 July 2017

Xiang-Xiang Wang

1

1 reference

29 July 2017

Meng-Shan Tan

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

24 June 2014

3 references

BioMed Research International

29 July 2017

25 April 2019

28 September 2019

3 references

29 July 2017

25 April 2019

28 September 2019

2014

1 reference

29 July 2017

page(s)

908636

1 reference

Creative Commons Attribution 3.0 Unported

29 July 2017

copyright license

2 references

25 April 2019

on focus list of Wikimedia project

28 September 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Estrogen activates matrix metalloproteinases-2 and -9 to increase beta amyloid degradation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Nuclear localization of matrix metalloproteinases.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Structural Basis for Matrix Metalloproteinase-2 (MMP-2)-selective Inhibitory Action of -Amyloid Precursor Protein-derived Inhibitor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Increased matrix metalloproteinase 9 activity in mild cognitive impairment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Matrix metalloproteinase-9 controls NMDA receptor surface diffusion through integrin beta1 signaling

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Propagation of tau misfolding from the outside to the inside of a cell.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Restored degradation of the Alzheimer's amyloid-beta peptide by targeting amyloid formation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Abeta-degrading enzymes in Alzheimer's disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Abeta(1-40)-induced secretion of matrix metalloproteinase-9 results in sAPPalpha release by association with cell surface APP.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4094696

Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia.

5 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

The interaction of amyloid β and the receptor for advanced glycation endproducts induces matrix metalloproteinase-2 expression in brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Matrix metalloprotease-9 inhibition improves amyloid beta-mediated cognitive impairment and neurotoxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Human ProNGF: biological effects and binding profiles at TrkA, P75NTR and sortilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Matrix metalloproteinase 3 haplotypes and plasma amyloid beta levels: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Impact of the matrix metalloproteinase MMP-3 on dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-beta stimulation via the PI3K/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Matrix metalloproteinase-9, its tissue inhibitor(TIMP)-1 and CRP in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Cerebrospinal fluid soluble amyloid-β protein precursor as a potential novel biomarkers of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F908636

Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by beta-amyloid precursor protein-derived inhibitor

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25050378

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25050378

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2014/908636

1 reference

29 July 2017

1 reference

29 July 2017

1 reference